Skip to main content

Distinguished New Members to External Advisory Board

Read Time: 1 minute

Huntsman Cancer Institute in Winter

Huntsman Cancer Institute (HCI) at the University of Utah announces the appointment of four new members to its External Advisory Board (EAB): Olufunmilayo Olopade, MD, Jennifer Pietenpol, PhD, Leonidas C. Platanias, MD, PhD, and John Pounardjian, MBA.

Olopade is director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medicine in Illinois. She is an expert in cancer risk assessment and personalized treatment for the most aggressive breast cancers.

Pietenpol is director of the Vanderbilt-Ingram Cancer Center and executive vice president for research at Vanderbilt University Medical Center in Nashville, Tennessee. Her research focuses on breast cancer.

Platanias is director of the Robert H. Lurie Comprehensive Cancer Center and professor of oncology at Northwestern University in Chicago, Illinois. His research focuses on cytokine pathway tumors.

Pounardjian is associate director of administration at the Case Comprehensive Cancer Center in Cleveland, Ohio. He is recognized broadly for his administrative expertise in the National Cancer Institute’s Cancer Center Support Grant (CCSG) and Specialized Programs of Research Excellence (SPORE) Grant.

The EAB is a consultative board charged with providing insight and advice to HCI leadership to inform strategic planning decisions. The board evaluates the scientific merit of HCI’s cancer research programs, the quality of clinical and translational programs, and the overall direction of HCI research. View the full roster of EAB members.

Media Contact

Heather Simonsen
Public Relations
Huntsman Cancer Institute
Email Us
801 581-3194

About Huntsman Cancer Institute at the University of Utah

Huntsman Cancer Institute at the University of Utah is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the highest standard of care and the most advanced treatments, ensuring world-class cancer care is available to all communities in the area we serve. We have more than 300 open clinical trials and 250 research teams studying cancer at any given time. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.

Resources for Media

Cancer touches all of us.